Small molecule sirtuin inhibitors and uses thereof
US-2025276953-A1 · Sep 4, 2025 · US
by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07D277/48 |
| Official title | by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines |
| Display label | by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines |
| Total patents | 39 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is growing.
| Year | Patents |
|---|---|
| 2015 | 8 |
| 2016 | 5 |
| 2017 | 7 |
| 2018 | 1 |
| 2020 | 4 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 4 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Chromobox protein inhibitors and uses thereof
US-2025034126-A1 · Jan 30, 2025 · US
Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto
US-RE50267-E · Jan 14, 2025 · US
Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto
US-2025009693-A1 · Jan 9, 2025 · US
Chromobox protein inhibitors and uses thereof
US-12129248-B2 · Oct 29, 2024 · US
CDK19-Selective Inhibitors, and Methods of Use Thereof
US-2024270735-A1 · Aug 15, 2024 · US
Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto
US-2023404954-A1 · Dec 21, 2023 · US
Carboxylic acid-containing compounds as modulators of bis-phosphoglycerate mutase for the treatment of sickle cell disease
US-2023348450-A1 · Nov 2, 2023 · US
Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto
US-2023121825-A1 · Apr 20, 2023 · US
Anti-cancer compositions and methods of use
US-2022304957-A1 · Sep 29, 2022 · US
Biguanide derivatives and their rearrangement products for use in the treatment of cancer
US-11440906-B2 · Sep 13, 2022 · US
Pesticidal compositions and methods
US-11332452-B2 · May 17, 2022 · US
Pesticidal compositions and methods
US-2021276963-A1 · Sep 9, 2021 · US
Haptens, hapten conjugates, compositions thereof and method for their preparation and use
US-11092594-B2 · Aug 17, 2021 · US
Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto
US-2020375930-A1 · Dec 3, 2020 · US
Biguanide derivatives and their rearrangement products for use in the treatment of cancer
US-2020308156-A1 · Oct 1, 2020 · US
Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto
US-10668033-B2 · Jun 2, 2020 · US
Chromobox protein inhibitors and uses thereof
US-2020024267-A1 · Jan 23, 2020 · US
Haptens, hapten conjugates, compositions thereof and method for their preparation and use
US-2018120306-A1 · May 3, 2018 · US
Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto
US-2017360730-A1 · Dec 21, 2017 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07D277/48?
- CPC C07D277/48 is the Cooperative Patent Classification code for “by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines.”
- How many patents are filed under CPC C07D277/48 (by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines)?
- Our database includes 39 publications tagged with this CPC code.
- Is patent activity under CPC C07D277/48 growing?
- Publication counts under this code: 2 in 2024 vs 4 in 2025 (latest complete years).